Aaron J Cohen1, Kanako Teramoto2, Brian Claggett3, Leo Buckley3, Scott Solomon3, Christie Ballantyne4, Elizabeth Selvin5, Amil M Shah6. 1. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: AJC284@GMAIL.COM. 2. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA; Division of Cardiology, St. Marianna University School of Medicine Hospital, Kanagawa, Japan. 3. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. 4. Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. 5. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA. 6. Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Electronic address: ashah11@rics.bwh.harvard.edu.
Abstract
BACKGROUND: Epidemiologic data supporting the association of accumulated inflammation from mid- to late life with late-life risk of cardiac dysfunction and heart failure (HF) is limited. METHODS AND RESULTS: Among 4011 participants in the Atherosclerosis Risk in Communities study who were free of prevalent cardiovascular disease at study Visit 5, accumulated inflammation was defined as time-averaged high-sensitivity c-reactive protein (hsCRP) over 3 visits spanning 1990 to 2013. Associations with left ventricular (LV) function at Visit 5 and with incident adjudicated HF post Visit 5 were assessed using linear and Cox regression, adjusting for demographics and comorbidities. Higher accumulated hsCRP was associated with greater LV mass index, lower e', higher E/e', and higher adjusting for demographics (all P ≤0.01), but only with higher pulmonary artery systolic pressure after adjustment for comorbidities (P = 0.024). At 5.3 ± 1.2 year follow-up, higher accumulated hsCRP was associated with greater risk of incident HF (HR 1.31 [95% CI 1.18-1.47], P < 0.001), HFrEF (1.26 [1.05-1.52], P = 0.01), and HFpEF (1.30 [1.11-1.53], P = 0.001) in demographic-adjusted models, but not after adjustment for comorbidities (all P > 0.10). Only Visit 5 hsCRP remained associated with incident HF (1.12 [1.02-1.24], P = 0.02) after full adjustment. CONCLUSIONS: Greater accumulated inflammation is associated with worse LV function and heightened HF risk in late-life. These relationships are attenuated after adjusting for HF risk factors. Published by Elsevier Inc.
BACKGROUND: Epidemiologic data supporting the association of accumulated inflammation from mid- to late life with late-life risk of cardiac dysfunction and heart failure (HF) is limited. METHODS AND RESULTS: Among 4011 participants in the Atherosclerosis Risk in Communities study who were free of prevalent cardiovascular disease at study Visit 5, accumulated inflammation was defined as time-averaged high-sensitivity c-reactive protein (hsCRP) over 3 visits spanning 1990 to 2013. Associations with left ventricular (LV) function at Visit 5 and with incident adjudicated HF post Visit 5 were assessed using linear and Cox regression, adjusting for demographics and comorbidities. Higher accumulated hsCRP was associated with greater LV mass index, lower e', higher E/e', and higher adjusting for demographics (all P ≤0.01), but only with higher pulmonary artery systolic pressure after adjustment for comorbidities (P = 0.024). At 5.3 ± 1.2 year follow-up, higher accumulated hsCRP was associated with greater risk of incident HF (HR 1.31 [95% CI 1.18-1.47], P < 0.001), HFrEF (1.26 [1.05-1.52], P = 0.01), and HFpEF (1.30 [1.11-1.53], P = 0.001) in demographic-adjusted models, but not after adjustment for comorbidities (all P > 0.10). Only Visit 5 hsCRP remained associated with incident HF (1.12 [1.02-1.24], P = 0.02) after full adjustment. CONCLUSIONS: Greater accumulated inflammation is associated with worse LV function and heightened HF risk in late-life. These relationships are attenuated after adjusting for HF risk factors. Published by Elsevier Inc.
Authors: Sameer Ather; Wenyaw Chan; Biykem Bozkurt; David Aguilar; Kumudha Ramasubbu; Amit A Zachariah; Xander H T Wehrens; Anita Deswal Journal: J Am Coll Cardiol Date: 2012-03-13 Impact factor: 24.094
Authors: Keenan A Walker; B Gwen Windham; Charles H Brown; David S Knopman; Clifford R Jack; Thomas H Mosley; Elizabeth Selvin; Dean F Wong; Timothy M Hughes; Yun Zhou; Alden L Gross; Rebecca F Gottesman Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472
Authors: Michael R Zile; Catalin F Baicu; John S Ikonomidis; Robert E Stroud; Paul J Nietert; Amy D Bradshaw; Rebecca Slater; Bradley M Palmer; Peter Van Buren; Markus Meyer; Margaret M Redfield; David A Bull; Henk L Granzier; Martin M LeWinter Journal: Circulation Date: 2015-01-30 Impact factor: 29.690
Authors: Loek van Heerebeek; Nazha Hamdani; Inês Falcão-Pires; Adelino F Leite-Moreira; Mark P V Begieneman; Jean G F Bronzwaer; Jolanda van der Velden; Ger J M Stienen; Gerrit J Laarman; Aernout Somsen; Freek W A Verheugt; Hans W M Niessen; Walter J Paulus Journal: Circulation Date: 2012-07-17 Impact factor: 29.690
Authors: Amil M Shah; Brian Claggett; Laura R Loehr; Patricia P Chang; Kunihiro Matsushita; Dalane Kitzman; Suma Konety; Anna Kucharska-Newton; Carla A Sueta; Thomas H Mosley; Jacqueline D Wright; Joseph Coresh; Gerardo Heiss; Aaron R Folsom; Scott D Solomon Journal: Circulation Date: 2016-11-23 Impact factor: 29.690
Authors: Sanjiv J Shah; Gregory M Marcus; Ivor L Gerber; Barry H McKeown; Joshua C Vessey; Mark V Jordan; Michele Huddleston; Elyse Foster; Kanu Chatterjee; Andrew D Michaels Journal: J Card Fail Date: 2006-02 Impact factor: 5.712
Authors: Francesco S Loffredo; Matthew L Steinhauser; Steven M Jay; Joseph Gannon; James R Pancoast; Pratyusha Yalamanchi; Manisha Sinha; Claudia Dall'Osso; Danika Khong; Jennifer L Shadrach; Christine M Miller; Britta S Singer; Alex Stewart; Nikolaos Psychogios; Robert E Gerszten; Adam J Hartigan; Mi-Jeong Kim; Thomas Serwold; Amy J Wagers; Richard T Lee Journal: Cell Date: 2013-05-09 Impact factor: 41.582